Pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Regulations’), GlaxoSmithKline Pharmaceuticals has informed that Registrar and Transfer Agent of Company - KFin Technologies has received request for issue of duplicate Share Certificates from Shareholders, Hemant Kumar Bhansaly & Meena Poladia further details enclosed. The company will issue the Letter of Confirmation only after the necessary formalities are carried out by the Shareholders.
The above information is a part of company’s filings submitted to BSE.
